Side Effects and Safety Profiles Because both forms contain semaglutide, their side-effect profiles are largely similar, such as: Nausea Vomiting Diarrhea Constipation These effects are typically dose-related and most noticeable during early treatment or dose increases
Doctors do not manufacture drugs
However, contrast this with the 2016 SUSTAIN-6 trial, in which the injectable form of semaglutide reduced cardiovascular events by 2.3 percentage points in diabetic patients
You should contact your doctor if your constipation becomes difficult to tolerate, if you experience severe abdominal pain, or if your constipation lasts more than a few days. Alex Nguyen, PharmD, RPh, CPhn Read more: When is constipation an emergency
2 Cooper Medical School of Rowan University, Camden, New Jersey, USA Correspondence: Garrett Chan, Email [email protected] Abstract: Tirzepatide is a GLP1/GIP receptor agonist that is used to treat type 2 diabetes and promote weight loss